Romazarit
Alternative Names: ORE 5007; RO 313948Latest Information Update: 16 Jul 2016
At a glance
- Originator Roche
- Developer Ore Pharmaceuticals
- Class Disease-modifying antirheumatics; Propionic acids; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Metabolic disorders